All articles by admin-demo 

  1. Is a robot about to steal my job?

    The Massachusetts Institute of Technology (MIT) at a recent Future of Work event hosted by BT at its London headquarters…
    Read More…

    19 Mar
  2. Future of semiconductor industry: Ten companies predicted to succeed

    Intel is the company which is best placed to succeed in the semiconductor sector, according to exclusive theme-based analysis. GlobalData…
    Read More…

    14 Mar
  3. ARCA biopharma to study Gencaro in Phase III trial

    ARCA biopharma has announced plans to investigate Gencaro (bucindolol hydrochloride) as a genetically-targeted therapy in a pivotal Phase III clinical…
    Read More…

    21 Feb
  4. BeiGene doses first patient in Phase II trial of zanubrutinib

    BeiGene has dosed the first patient in a global Phase II trial to evaluate the efficacy of zanubrutinib for the…
    Read More…

    21 Feb
  5. Intercept reports fibrosis improvement in NASH trial

    Intercept Pharmaceuticals has reported positive top-line results from the pivotal Phase III REGENERATE clinical trial of obeticholic acid (OCA) in…
    Read More…

    20 Feb
  6. Sosei Heptares initiates clinical programme for endocrine disorders

    Japan-based biopharmaceutical group Sosei Heptares has initiated the HTL0030310 clinical development programme for the treatment of endocrine disorders, including Cushing’s disease….
    Read More…

    20 Feb
  7. Novus Therapeutics begins dosing in otitis media drug trial

    Novus Therapeutics has commenced dosing in a Phase IIa clinical trial of OP0201 for the treatment of otitis media, an…
    Read More…

    20 Feb
  8. Pfizer-Lilly’s tanezumab reduces chronic low back pain in trial

    Pfizer and Eli Lilly have reported positive top-line results from a Phase III clinical trial of tanezumab in patients suffering…
    Read More…

    20 Feb
  9. Inventiva’s lanifibranor fails to meet endpoint in FASST trial

    French biopharmaceutical company Inventiva has reported findings from the Phase IIb FASST clinical trial of lanifibranor in patients with diffuse…
    Read More…

    19 Feb
  10. Bionomics reports additional data from RESTORE trial

    Australia-based Bionomics has reported positive data from additional analysis of the Phase II RESTORE trial that evaluated its BNC210 in…
    Read More…

    19 Feb
Close
Close
Close

Go Top